Literature DB >> 4019778

Influx of kininogens into nasal secretions after antigen challenge of allergic individuals.

C R Baumgarten, A G Togias, R M Naclerio, L M Lichtenstein, P S Norman, D Proud.   

Abstract

We have recently demonstrated that kinins are generated in vivo after nasal challenge with antigen of allergic, but not nonallergic, individuals. The present study was undertaken as a first step in determining the mechanism(s) of kinin formation during the allergic reaction and was directed towards establishing the availability and origin of kininogens in nasal secretions. Allergic individuals (n = 6) and nonallergic controls (n = 5) were challenged with antigen; and by using specific radioimmunoassays, nasal washes, obtained before and after challenge, were assayed for high molecular weight kininogen (HMWK), total kininogen (TK), albumin, and kinins. Dramatic increases in HMWK (1,730 +/- 510 ng/ml), TK (3,810 +/- 1035 ng/ml), kinin (9.46 +/- 1.75 ng/ml), and albumin (0.85 +/- 0.2 mg/ml) were observed after challenge of allergic individuals which correlated (P less than 0.001) with increases in histamine and N-alpha-tosyl-L-arginine methyl esterase activity and with the onset of clinical symptoms. For nonallergic individuals, levels of kininogens, albumin, and all mediators after antigen challenge were not different from base line. Linear regression analysis revealed excellent correlations (P less than 0.001 in each case) between increases in HMWK, TK, kinin, and albumin during antigen titration experiments and between the time courses of appearance and disappearance of HMWK, TK, kinin, and albumin after antigen challenge. Gel filtration revealed no evidence of degradation products of kininogens in nasal washes. For each allergic individual the ratio of HMWK/TK in postchallenge nasal washes was similar to the ratio of these two proteins in the same individual's plasma. These data suggest that, during the allergic reaction, there is an increase in vascular permeability and a transudation of kininogens from plasma into nasal secretions, where they can provide substrate for kinin-forming enzymes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4019778      PMCID: PMC423741          DOI: 10.1172/JCI111945

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  The nature of the kallidins released from human plasma by kallikreins and other enzymes.

Authors:  M E WEBSTER; J V PIERCE
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

2.  Kinin-converting aminopeptidase from human serum.

Authors:  J A Guimarães; D R Borges; E S Prado; J L Prado
Journal:  Biochem Pharmacol       Date:  1973-12-15       Impact factor: 5.858

3.  Quantitative determination of immunoglobulins in nasal secretion.

Authors:  N Mygind; B Weeke; S Ullman
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

Review 4.  The biochemistry and pathophysiology of the contact system of plasma.

Authors:  C G Cochrane; J H Griffin
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

5.  The possible role of bradykinin as a mediator in bronchial asthma.

Authors:  M Brenner; C Baumgarten; G Kunkel; R Rudolph; E Kirchhof
Journal:  Allergol Immunopathol (Madr)       Date:  1982 Nov-Dec       Impact factor: 1.667

Review 6.  Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation.

Authors:  A P Kaplan; M Silverberg; J T Dunn; B Ghebrehiwet
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  Characterization and localization of human renal kininogen.

Authors:  D Proud; M Perkins; J V Pierce; K N Yates; P F Highet; P L Herring; M Mangkornkanok/Mark; R Bahu; F Carone; J J Pisano
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

8.  Observations on the kallikrein-kinin system in the kidney.

Authors:  J J Pisano
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

9.  Inactivation of human high molecular weight kininogen by human mast cell tryptase.

Authors:  M Maier; J Spragg; L B Schwartz
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

10.  High-molecular weight kininogen. A secreted platelet protein.

Authors:  A H Schmaier; A Zuckerberg; C Silverman; J Kuchibhotla; G P Tuszynski; R W Colman
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

View more
  17 in total

1.  Kinin generation following methacholine nasal airway challenge of non-allergic subjects.

Authors:  C R Baumgarten; W Niemz; G Kunkel
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Reversibility and reproducibility of histamine induced plasma leakage in nasal airways.

Authors:  C Svensson; C R Baumgarten; U Pipkorn; U Alkner; C G Persson
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

3.  A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin.

Authors:  J A Pongracic; R M Naclerio; C J Reynolds; D Proud
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

Review 4.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

5.  Conjunctival provocative tests: a model of human ocular allergy.

Authors:  M H Friedlaender
Journal:  Trans Am Ophthalmol Soc       Date:  1989

6.  Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.

Authors:  U Pipkorn; D Proud; L M Lichtenstein; R P Schleimer; S P Peters; N F Adkinson; A Kagey-Sobotka; P S Norman; R M Naclerio
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 7.  Late-phase IgE-mediated reactions.

Authors:  R F Lemanske; M Kaliner
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

8.  Immunology of allergic rhinitis, or a nose for treatment.

Authors:  V J Lund; D J Wright; R J Davies
Journal:  J R Soc Med       Date:  1986-10       Impact factor: 5.344

9.  Localization of immunoreactive tissue kallikrein in the seromucous glands of the human and guinea-pig respiratory tree.

Authors:  M T Poblete; G Garces; C D Figueroa; K D Bhoola
Journal:  Histochem J       Date:  1993-11

10.  Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig.

Authors:  C Advenier; Y Qian; J D Koune; M Molimard; M L Candenas; E Naline
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.